MedPath

National Cancer Center Korea

National Cancer Center Korea logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1989-01-01
Employees
-
Market Cap
-
Website
http://www.ncc.re.kr

A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast Cancer

Phase 2
Conditions
Breast Cancer
Interventions
First Posted Date
2016-06-29
Last Posted Date
2016-06-29
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
149
Registration Number
NCT02817334
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Endoscopic Full Thickness Resection Without Exposure to Peritoneum

Phase 1
Conditions
Submucosal Tumor of Stomach
Interventions
Procedure: simple non-exposure EFTR
First Posted Date
2016-05-06
Last Posted Date
2016-05-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
12
Registration Number
NCT02764944
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy

Phase 2
Completed
Conditions
Anemia
Pancreatic Cancer
Interventions
Drug: Ferinject (Ferric Carboxymaltose)
First Posted Date
2015-12-11
Last Posted Date
2020-04-28
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
40
Registration Number
NCT02628860
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

Preoperative Nutritional Support in Malnutritional Cancer Patients

Not Applicable
Completed
Conditions
Malnutrition
Pancreatic Cancer
Biliary Cancer
Interventions
Dietary Supplement: nutritional support program
First Posted Date
2015-12-10
Last Posted Date
2018-06-11
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
50
Registration Number
NCT02626195
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

MAC Bipsectral Index Below 50 for Chronic Opioid User

Not Applicable
Conditions
Anesthesia
Interventions
Other: History for opioid use
First Posted Date
2015-10-21
Last Posted Date
2015-10-21
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
20
Registration Number
NCT02582437
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, National Cancer Center, Goyang-si, Gyeonggi-do 10408, Korea, Republic of

Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection

Phase 2
Conditions
Gastric Cancer
Interventions
Procedure: Distal Gastrectomy with D2 LND
First Posted Date
2015-10-08
Last Posted Date
2016-04-20
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
87
Registration Number
NCT02572050
Locations
🇰🇷

National Cancer Center of Korea, Goyang, Gyeonggi-do, Korea, Republic of

🇰🇷

Aju University Hospital, Suwon, Gyeonggi-do, Korea, Republic of

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

Phase 3
Completed
Conditions
Helicobacter Pylori Infection
Family History of Stomach Cancer
Interventions
Drug: Standard triple therapy
Drug: Bismuth quadruple therapy
First Posted Date
2015-09-23
Last Posted Date
2020-04-08
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
352
Registration Number
NCT02557932
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of

Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation

Phase 3
Completed
Conditions
Healthy
Interventions
Drug: HAPREP®
Drug: SUCLEAR®
First Posted Date
2015-09-16
Last Posted Date
2019-01-17
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
184
Registration Number
NCT02551198
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy

Phase 2
Conditions
Rectal Cancer
Interventions
Procedure: Local excision
First Posted Date
2015-07-07
Last Posted Date
2015-07-07
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
86
Registration Number
NCT02490709
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

Not Applicable
Conditions
Breast Cancer
Interventions
Behavioral: Decision aids (tamoxifen-related educational materials in brochure or mobile app)
First Posted Date
2015-07-02
Last Posted Date
2015-07-02
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
360
Registration Number
NCT02488603
© Copyright 2025. All Rights Reserved by MedPath